Compound Yuxingcao Mixture Group:Refer to the National Health Office Medical Letter (2020) 77 document "Diagnosis and treatment plan for the novel coronavirus disease (trial version 5)" general treatm
Sponsors
Affiliated Hospital of traditional Chinese and Western Medicine Nanjing University of Chinese Medicine
Conditions
Novel Coronavirus Pneumonia (COVID-19)
Early Phase 1
Cancelled by the investigator Study for the Effectiveness and Safety of Compound Yuxingcao Mixture in the Treatment of the Novel Coronavirus Pneumonia (COVID-19)
Active, not recruitingITMCTR2000003079
Start: 2020-02-26Updated: 2023-02-20
Cancelled by the investigator Study for the Effectiveness and Safety of Compound Yuxingcao Mixture in the Treatment of the Novel Coronavirus Pneumonia (COVID-19)
Active, not recruitingChiCTR2000030478
Start: 2020-02-26Updated: 2020-03-16